Screener
Agios Pharmaceuticals AGIO Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue, net | $44,745 | $12,455 | $65,491 | $21,181 |
| Total revenue | 44,745 | 12,455 | 65,491 | 21,181 |
| Operating expenses: | ||||
| Cost of sales | $2,996 | $1,702 | $4,315 | $2,787 |
| Research and development | 100,754 | 91,940 | 181,902 | 164,683 |
| Selling, general and administrative | 51,547 | 45,869 | 99,851 | 87,396 |
| Total operating expenses | 155,297 | 139,511 | 286,068 | 254,866 |
| Loss from operations | (110,552) | (127,056) | (220,577) | (233,685) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's total cost of revenue?
- Agios Pharmaceuticals (AGIO) reported total cost of revenue of $3M in Q2 2026.
- How has Agios Pharmaceuticals's total cost of revenue changed year-over-year?
- Agios Pharmaceuticals's total cost of revenue increased by 76.0% year-over-year, from $1.7M to $3M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Agios Pharmaceuticals's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude